HPA

MARCH 15, 2022

We’re excited to share that metaMe Health , a prescription digital therapeutics (PDT) company, today announced raising $2.2M We are thrilled to have the support of HPA as we prepare for the launch of Regulora,” said Tim Rudolphi, CEO of metaMe Health. “We in funding. and chief legal officer at Takeda Pharmaceuticals U.S.A.,

health 113

health digital therapeutics board support 113

HPA

MARCH 15, 2022

We’re excited to share that metaMe Health , a prescription digital therapeutics (PDT) company, today announced raising $2.2M We are thrilled to have the support of HPA as we prepare for the launch of Regulora,” said Tim Rudolphi, CEO of metaMe Health. “We in funding. and chief legal officer at Takeda Pharmaceuticals U.S.A.,

health 91

health digital therapeutics board support 91

Angel Capital Association

MAY 18, 2020

MedRhythms, a Portland, Maine-based digital therapeutics company, is building direct stimulation, prescription therapeutics that use sensors, music, and software to improve loss of mobility caused by neurologic injuries and diseases. How does MedRhythms’ technology work?

digital therapeutics 40

digital therapeutics hospitality angel capital economic development 40

Y Combinator

MARCH 2, 2021

Whether you’re pursuing an IND or an IDE, you’ll have to fully explain what you want to study, who your investigators are, how safe the product is, what type of patient consent you’re requesting, and what institutional review board (IRB) has reviewed and cleared your studies. Marketing Approval.

startup 59

startup health development digital therapeutics 59